REQUEST A DEMO
Total
USD $0.00
Search more companies

Cortimed Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Advertising Agencies | Convention and Trade Show Organizers | Electronic and Precision Equipment Repair and Maintenance | Other Electronic and Precision Equipment Repair and Maintenance
Full name: Cortimed Sp. z o.o. Profile Updated: January 21, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Cortimed Sp. z o.o. is a company in Poland, with a head office in Myslenice. It operates in the Pharmacies and Drug Stores industry. It was incorporated on July 15, 2021. In its most recent financial highlights, the company reported a net sales revenue increase of 79.29% in 2025. Its’ total assets recorded a growth of 135.11%. In 2025, Cortimed Sp. z o.o.’s net profit margin decreased by 4.5%.

Headquarters
Ul. Zwirki I Wigury 10
Myslenice; Malopolskie; Postal Code: 32-400

Contact Details: Purchase the Cortimed Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Cortimed Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Cortimed Sp. z o.o. report to view the information.
Incorporation Date:
July 15, 2021
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Cortimed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
79.29%
Total Operating Revenue
79.29%
Operating Profit
-45.5%
EBITDA
33.94%
Net Profit/Loss for the Period
-45.44%
Total Assets
135.11%
Total Equity
40.32%
Operating Profit Margin
-4.94%
Net Profit Margin
-4.5%
Return on Equity (ROE)
-31.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?